Yamaguchi, Takanori Otsubo, Toyokazu Takahashi, Yuya Nakashima, Kana Fukui, Akira Hirota, Kei Ishii, Yumi Shinzato, Kodai Osako, Ryosuke Tahara, Mai
...
Published in
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Low‐voltage areas (LVAs) in the atria of patients with atrial fibrillation are considered local fibrosis. We hypothesized that voltage reduction in the atria is a diffuse process associated with fibrosis and that the presence of LVAs reflects a global voltage reduction. Methods and Results We examined 140 patients with atrial fibrillatio...
Boursiquot, Brian C. Bellettiere, John LaMonte, Michael J. LaCroix, Andrea Z. Perez, Marco V.
Published in
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Sedentary behavior is associated with cardiovascular disease, but its association with incident atrial fibrillation is not well studied. Our aim was to measure the association between objectively measured sedentary behavior and incident atrial fibrillation. Methods and Results Sedentary behavior was measured by a triaxial accelerometer w...
Bayer, Valentina Kotalczyk, Agnieszka Kea, Bory Teutsch, Christine Larsen, Peter Button, Dana Huisman, Menno V. Lip, Gregory Y. H. Olshansky, Brian
Published in
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Effective stroke prevention with oral anticoagulants (OAC) is recommended for some patients with atrial fibrillation (AF). We aimed to describe OAC use by geographical region and type of site in patients with recent‐onset AF enrolled in a large global registry. Methods and Results Eligible participants were recruited into GLORIA‐AF (Glob...
Camm, A. John Blomström-Lundqvist, Carina Boriani, Giuseppe Goette, Andreas Kowey, Peter R. Merino, Jose L. Piccini, Jonathan P. Saksena, Sanjeev Reiffel, James A.
Background: Guideline recommendations are the accepted reference for selection of therapies for rhythm control of atrial fibrillation (AF). This study was designed to understand physicians' treatment practices and adherence to guidelines. Methods and Results: The AIM-AF (Antiarrhythmic Medication for Atrial Fibrillation) study was an online survey ...
Chahine, Mohamed Fontaine, John M. Boutjdir, Mohamed
Published in
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Cardiovascular disease (CVD) continues to be the most common cause of death worldwide, and cardiac arrhythmias account for approximately one half of these deaths. The morbidity and mortality from CVD have been reduced significantly over the past few decades; however, disparities in racial or ethnic populations still exist. This review is based on a...
Sciera, Lucca Katrine Frost, Lars Dybro, Lars Poulsen, Peter Bo
Published in
European heart journal. Quality of care & clinical outcomes
The objective was to evaluate the cost-effectiveness of one-time opportunistic screening for atrial fibrillation (AF) in general practice in citizens aged ≥65 years in Denmark compared to a no-screening alternative following current Danish practice. A decision tree and a Markov model were designed to simulate costs and quality-adjusted life years (...
Butzner, Michael Leslie, Douglas Cuffee, Yendelela Hollenbeak, Christopher S Sciamanna, Christopher Abraham, Theodore P
ObjectivesTo evaluate sex differences in demographic and clinical characteristics, treatments and outcomes for patients with diagnosed obstructive hypertrophic cardiomyopathy (oHCM) in the USA.SettingRetrospective observational study of administrative claims data from MarketScan Commercial Claims and Encounters Database from IBM Watson Health.Parti...
Teppo, Konsta Jaakkola, Jussi Airaksinen, K. E. Juhani Biancari, Fausto Halminen, Olli Putaala, Jukka Mustonen, Pirjo Haukka, Jari Hartikainen, Juha Luojus, Alex
...
Published in
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Mental health conditions (MHCs) are associated with poor outcomes in patients with atrial fibrillation. However, persistence of oral anticoagulation therapy in patients with atrial fibrillation and MHCs is unknown. We aimed to evaluate the effect of MHCs on the persistence of direct oral anticoagulant (DOAC) use in patients with atrial f...
Vinding, Naja E. Butt, Jawad H. Olesen, Jonas B. Xian, Ying Kristensen, Søren Lund Rørth, Rasmus Bonde, Anders Nissen Gundlund, Anna Yafasova, Adelina Weeke, Peter E.
...
Published in
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Oral anticoagulation (OAC) is effective for stroke prevention in patients with atrial fibrillation. However, some patients experience stroke despite OAC therapy, and knowledge about the impact of prior treatment quality is lacking. Methods and Results Patients with atrial fibrillation on OAC therapy who had a first‐time ischemic stroke w...
Zhong, Xia Jiao, Huachen Zhao, Dongsheng Teng, Jing
Published in
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background Although serum uric acid (SUA) levels have been reported to be associated with atrial fibrillation (AF), the specific associations remain unclear. The purpose of this study was to investigate the potential relationship of serum uric acid levels to atrial fibrillation. Material/Methods We retrospectively analyzed clinical data of 970 cons...
